Paris PVT Meeting 2022

Day 1, November 29th 2022

8h30-8h50 Welcome of participants
8h50-9h: Opening and introductory words

9h-12h30 Session 1: Non cirrhotic PVT
9h-10h30
Causes and underlying mechanisms – J Poisson, France
Impact of etiological therapy – C Bureau, France
Pathophysiology of portal hypertension in PVT without cirrhosis : similarities
and differences with cirrhosis – JC Garcia Pagan, Spain

10h30-11h Break

11h-12h30
Noninvasive tests versus liver biopsy? – L Elkrief, France
PSVD and PVT: two separate entities? – V Paradis, France
Anticoagulation in patients with recent and chronic PVT – A Plessier, France

12h30-14h Lunch break

14h-15h30 Session 2: PVT in patients with cirrhosis
Epidemiology and risk factors – F Nery, Portugal
Impact treating the cause of cirrhosis – M Mandorfer, Austria
Anticoagulation in patients with cirrhosis to prevent and treat PVT and to
prevent decompensation – A Albillos, Spain
When and how to treat PVT in a patient with simultaneous HCC (excluding PV
invasion)? – M Senzolo, Italy
Management of PVT before and after liver transplantation – F Durand, France / C Toso, Switzerland

15h30-16h Break

16h-18h Session 3: Specificity of the portal venous system
Specificity of the portal vein wall in cirrhosis (15 min + 15 min discussion) – V Hernandez-Gea, Spain
Specificity of the portal blood in cirrhosis (15 min + 15 min discussion) – Ton Lisman, Netherlands
State of the art lecture : Immuno-thrombosis – Konstantin Stark, Germany

 

Day 2, November 30th 2022

8h30-10h Session 4: Management of PVT without and with cirrhosis
PVT and cirrhosis: what place for anticoagulation and for interventional
radiology? – D Tripathi, UK / Lara Roberts, UK
PVT without cirrhosis: what place for anticoagulation and for interventional
radiology? – A de Gottardi, Switzerland / R Salem, USA
Prevention and management of variceal bleeding in PVT without and with
cirrhosis: should that really be the same as in cirrhosis? – D Patch, UK

10h-10h30 Break

10h30-12h30 Session 5: Specific issues in PVT without cirrhosis
10h30-11h30
Impact on quality of life – A Baiges, Spain
Fertility, contraception and pregnancy – A Payancé, France
PVT in children: specificities as compared with adults – V McLin, Switzerland
Role of patient’s associations in student’s training – S Hullin, AMVF, France
Common discussion

11h30 – 12h30
Portal cholangiopathy – A Shukla, India
Chronic abdominal pain, chronic enteropathy, mesenteric ischemia and intestinal necrosis – A Nuzzo, France
Symptomatic hypersplenism – S Sarin, India
Management of PVT in patients with pancreatic cancer and pancreatitis – M Primignani, Italy
Common discussion

12h30 – 13h30 Lunch break

13h30-18h Session 6: Consensus discussion : endpoints for studies in portal vein thrombosis
Classification of portal vein thrombus extension – M Ronot, France
Classification of portal vein thrombosis evolution – P Northup, USA

15h30-16h Break

Timing of assessment – A Berzigotti, Switzerland
Goal of the treatment in patients with portal vein thrombosis – S Darwish Murad, the Netherlands

17h30-18h Concluding remarks